The demand for endoluminal suturing devices in the UK is slated to total USD 8.5 million in 2026, and is forecasted to climb further to USD 15.2 million by 2036, advancing at a 6.0% CAGR. Bariatric procedures will dominate with a 41.0% share while needle-based suturing devices will lead by product type with a 55.0% share.